Terms: = Head and neck cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
28 results:
1. treatment for smarcb1 (INI-1) deficient sinonasal tumor: a single-institution study.
Wang T; Wang J; Tang T; Wang L; Li Y; Song X
Neoplasma; 2023 Dec; 70(6):804-810. PubMed ID: 38247337
[TBL] [Abstract] [Full Text] [Related]
2. The medial transorbital approach in cranioendoscopic skull base tumor resections for locally advanced tumors.
Scholfield DW; Levyn H; Tabar VS; Ganly I; Della Rocca D; Cohen MA
J Clin Neurosci; 2024 Jan; 119():198-204. PubMed ID: 38134571
[TBL] [Abstract] [Full Text] [Related]
3. Higher Rates of Inadequate Adjuvant Radiation Dose Among Older Adults with head and neck cancer.
Raab G; Babu C; Yu Y; Givi B; Wong RJ; Lee NY; Zakeri K
Laryngoscope; 2024 May; 134(5):2206-2211. PubMed ID: 37983853
[TBL] [Abstract] [Full Text] [Related]
4. smarcb1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract] [Full Text] [Related]
5. IDH2 -Mutated Sinonasal Tumors: A Review.
Alzumaili B; Sadow PM
Adv Anat Pathol; 2023 Mar; 30(2):104-111. PubMed ID: 36537260
[TBL] [Abstract] [Full Text] [Related]
6. p53 Pathway Inactivation Drives smarcb1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.
Oppel F; Shao S; Gendreizig S; Zimmerman MW; Schürmann M; Flavian VF; Goon P; Chi SN; Aster JC; Sudhoff H; Look AT
Mol Cancer Ther; 2022 Nov; 21(11):1689-1700. PubMed ID: 36099437
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of the diagnosis and treatment of patients with smarcb1 (INI-1)-deficient sinonasal carcinoma].
Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
[No Abstract] [Full Text] [Related]
8. Clinical Diagnosis and treatment Analyses on smarcb1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma: Case Series with Systematic Review of the Literature.
Wang R; Wang L; Fang J; Zhong Q; Hou L; Ma H; Feng L; He S; Wang C; Zhang L
World Neurosurg; 2022 May; 161():e229-e243. PubMed ID: 35123020
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a glioma functional network from gene fitness data using machine learning.
Xiang CX; Liu XG; Zhou DQ; Zhou Y; Wang X; Chen F
J Cell Mol Med; 2022 Feb; 26(4):1253-1263. PubMed ID: 35044082
[TBL] [Abstract] [Full Text] [Related]
10. Emerging concepts in sinonasal tumor research.
Lopez DC; Wadley AE; London NR
Curr Opin Otolaryngol Head Neck Surg; 2022 Feb; 30(1):33-39. PubMed ID: 34958321
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathological characteristics of smarcb1(ini1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
12. Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
Heft Neal ME; Birkeland AC; Bhangale AD; Zhai J; Kulkarni A; Foltin SK; Jewell BM; Ludwig ML; Pinatti L; Jiang H; McHugh JB; Marentette L; McKean EL; Brenner JC
BMC Cancer; 2021 May; 21(1):636. PubMed ID: 34051734
[TBL] [Abstract] [Full Text] [Related]
13. Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
Taghizadeh H; Müllauer L; Mader RM; Füreder T; Prager GW
Wien Klin Wochenschr; 2021 Jan; 133(1-2):32-40. PubMed ID: 33296026
[TBL] [Abstract] [Full Text] [Related]
14. INI-1 (smarcb1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract] [Full Text] [Related]
15. smarcb1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract] [Full Text] [Related]
16. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract] [Full Text] [Related]
17. smarcb1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
Neves-Silva R; Almeida LY; Silveira HA; Colturato CBN; Duarte A; Ferrisse TM; Silva EV; Vanzolin BF; Bufalino A; Ribeiro-Silva A; León JE
Head Neck; 2020 Mar; 42(3):374-384. PubMed ID: 31729110
[TBL] [Abstract] [Full Text] [Related]
18. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract] [Full Text] [Related]
19. smarcb1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
Trieu V; Aulet RM; Ciolino A; Rimash T
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
[TBL] [Abstract] [Full Text] [Related]
20. Poorly Differentiated Chordomas Showing Loss of ini1/smarcb1: A Report of 2 Rare Cases With Diagnostic Implications.
Rekhi B; Kosemehmetoglu K; Rane S; Soylemezoglu F; Bulut E
Int J Surg Pathol; 2018 Oct; 26(7):637-643. PubMed ID: 29623728
[TBL] [Abstract] [Full Text] [Related]
[Next]
